Dawnrays Pharmaceutical (Holdings) Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 1,151.15 million compared to CNY 1,277.68 million a year ago. Net income was CNY 326 million compared to CNY 358.06 million a year ago.

Basic earnings per share from continuing operations was CNY 0.2174 compared to CNY 0.2389 a year ago. Diluted earnings per share from continuing operations was CNY 0.217 compared to CNY 0.2383 a year ago.